Loading
Icon PLC Stock: price and insider trades · United States
US·Mcap US$13.1B
Icon PLC: what insiders have been doing
Icon PLC is a listed company based in Ireland, Ireland, founded in 1990. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 18 October 2026, brought 62 filings signed by 18 insiders.
No insider bought on the market over the period, while 9 insiders filed 37 sales totalling €3.5M. At €764k, the sale published on 18 September 2026 by Murphy Ronan Martin is the largest of the period (0.0065% of market cap).
For context, the typical company on the same exchange (median of 5,458 companies) published 22 filings over the same period, against 62 filings here. Looking back to 2026, when coverage begins, insiders filed no purchases and 37 sales.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
62
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€4M
37 ops. · all time
Who traded when
BuySaleEugene Pacelli McCague5 sales
John Dr Climax5 sales
Ronan Martin Murphy5 sales
Anne Clem Whitaker4 sales
Linda Grais4 sales
Murray Ciaran4 sales
+3 other insiders
Analyst consensus: bullish or bearish?
Analysts rate Icon PLC Buy (bullish), based on 16 analysts. Average price target: US$185.25.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,658 of 24,148 companies
39.0
score / 100
Value46
Quality32
FCF yld6.6%
Earn yld1.7%
EV/EBITDA20.3x
ROE0.3%
Gross mgn26%
Net mgn2.8%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$170.35
Analyst consensus
16 analystsBuy
US$155.00Target US$185.25(+9%)US$220.00
Income statement
RevenueUS$8.3B
Gross profitUS$2.2B26% margin
EBITDAUS$823.6M10% margin
Net incomeUS$229.3M0.3% margin
Valuation
PER (trailing)270.4x
PER (forward)14.4x
P/Book1.4x
Beta1.20
Balance sheet & cash
Market capUS$13.1B
Total debtUS$3.6B
Free Cash FlowUS$862M
Debt / Equity38%
Profitability & ownership
ROE0.3%
ROA1.0%
% insiders0.4%
% institutions108.7%
Last declaration on 18 September 2026
Declarations62 total
5,005 shares@ US$125.740.0047% mcap38.3% of flowOrdinary SharesSEC:0001628280-26-062607:0
5,005 shares@ US$175.000.0065% mcap53.3% of flowOrdinary SharesSEC:0001628280-26-062607:1
3,255 shares@ US$125.740.0030% mcap36.7% of flowOrdinary SharesSEC:0001628280-26-062608:0
3,255 shares@ US$175.000.0042% mcap51.0% of flowOrdinary SharesSEC:0001628280-26-062608:1
5,005 shares@ US$125.740.0046% mcap38.3% of flowOrdinary SharesSEC:0001628280-26-062609:0
5,005 shares@ US$175.000.0064% mcap53.3% of flowOrdinary SharesSEC:0001628280-26-062609:1
3,255 shares@ US$175.000.0045% mcap80.6% of flowCommonSEC144:0001950047-26-009603
5,005 shares@ US$175.000.0069% mcap86.5% of flowCommonSEC144:0001950047-26-009602
5,005 shares@ US$175.000.0068% mcap86.4% of flowCommonSEC144:0001950047-26-009549
1,732 sharesOrdinary SharesSEC:0001628280-26-056301:0
3,375 sharesOrdinary SharesSEC:0001628280-26-056296:1
1,732 sharesOrdinary SharesSEC:0001628280-26-056304:0
1,732 sharesOrdinary SharesSEC:0001628280-26-056328:0
67 shares@ US$165.510.0001% mcap0.7% of flowOrdinary SharesSEC:0001628280-26-056301:4
67 shares@ US$165.510.0001% mcap0.7% of flowOrdinary SharesSEC:0001628280-26-056324:4
918 sharesOrdinary SharesSEC:0001628280-26-056296:0
95 shares@ US$163.770.0001% mcap0.9% of flowOrdinary SharesSEC:0001628280-26-056301:2
591 shares@ US$164.470.0007% mcap5.9% of flowOrdinary SharesSEC:0001628280-26-056301:3
237 shares@ US$162.720.0003% mcap10.4% of flowOrdinary SharesSEC:0001628280-26-056296:2
259 shares@ US$163.770.0003% mcap11.4% of flowOrdinary SharesSEC:0001628280-26-056296:3
1,591 shares@ US$164.470.0019% mcap70.3% of flowOrdinary SharesSEC:0001628280-26-056296:4
180 shares@ US$165.510.0002% mcap8.0% of flowOrdinary SharesSEC:0001628280-26-056296:5
87 shares@ US$162.720.0001% mcap10.2% of flowOrdinary SharesSEC:0001628280-26-056304:1
97 shares@ US$163.770.0001% mcap11.5% of flowOrdinary SharesSEC:0001628280-26-056304:2
590 shares@ US$164.470.0007% mcap70.2% of flowOrdinary SharesSEC:0001628280-26-056304:3
25 of 62 declarations
About Icon PLC
Icon PLC is a clinical research organization that provides services to the pharmaceutical and biopharmaceutical industries. It specializes in drug development and the management of clinical trials.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
